Skin conditions in early Parkinson's disease

Deepika Dinesh,Jong Soo Lee,Xiang Gao,Natalia Palacios

DOI: https://doi.org/10.1016/j.parkreldis.2021.01.018

2021-03-01

Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Objective</h3><p>Skin conditions have been associated with increased risk of Parkinson's disease (PD). Little is known about clinical and biomarker differences according to presence of skin conditions among PD patients. Studying these differences might provide insight into PD pathogenesis.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>We examined the association between common skin conditions and risk of PD in a case-control study of 423 early drug-naïve PD cases and 196 healthy controls (HC) in the Parkinson's Progression Markers Initiative (PPMI). Among PD participants, we examined if skin conditions were associated with clinical and PD-relevant biomarkers.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Skin conditions occurred more frequently among PD participants (41%) relative to HC (32%). In multivariate analyses, we observed an association between any skin condition and PD (OR=1.49, 95% CI= 1.03-2.16) and basal cell carcinoma and PD (OR=2.05, 95% CI=1.02- 4.08). PD participants who reported skin conditions were older (OR=1.68, 95% CI=1.21-2.35,) more educated (OR=1.70, 95% CI=0.99-2.91), had higher Semantic Fluency Test (SFT) scores (OR=1.45, 95% CI=1.07-1.96) and Hopkins Verbal Learning Test (HVLT) retention scores (OR=1.55, 95% CI= 1.09-2.22) compared to PD patients without skin conditions. None of the associations remained significant after Bonferroni correction for multiple comparisons.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>We observed a positive association between any skin condition as well as basal cell carcinoma and PD. PD participants with skin conditions were older, more educated, had higher SFT and HVLT retention scores compared to those without skin conditions. However, all associations were no longer significant after Bonferroni multiple comparisons correction. Observed associations should be confirmed in larger, longitudinal studies.</p>

clinical neurology

What problem does this paper attempt to address?

This paper attempts to explore the association between skin conditions and Parkinson's Disease (PD), and further analyze whether there is an impact of skin conditions on the clinical manifestations and related biomarkers in PD patients. Specifically, the main objectives of the study include:

1. **Evaluating the relationship between skin conditions and PD risk**: By comparing the data of 423 early - stage, drug - naive PD patients and 196 healthy controls (HC), the researchers hope to understand whether common skin conditions are related to an increased risk of PD.

2. **Exploring the impact of the presence of skin conditions on clinical features and biomarkers in PD patients**: Among PD patients, the researchers further investigated whether skin conditions are related to the severity of PD, cognitive function, and other non - motor symptoms, and whether there are differences in biomarkers (such as α - synuclein, total tau protein, phosphorylated tau protein, and β - amyloid 1 - 42) in these patients.

### Research methods

- **Participant selection**: The data were obtained from the Parkinson's Progression Markers Initiative (PPMI) database, including 423 recently diagnosed, drug - naive PD patients and 196 healthy controls without significant neurological deficits.
- **Ethical review**: The study followed the standards of Good Clinical Practice (GCP) and the International Conference on Harmonization (ICH).
- **Skin condition assessment**: Skin conditions were assessed through the participants' medical records, with a focus on common inflammatory skin conditions, such as eczema, psoriasis, rosacea, seborrheic dermatosis, and skin cancer.
- **Covariate assessment**: Including age, gender, education level, non - steroidal anti - inflammatory drug (NSAID) use, etc.
- **Clinical feature assessment**: Multiple scales were used to assess the severity of PD, motor and non - motor symptoms, including MDS - UPDRS, RBD questionnaire, Epworth Sleepiness Scale (ESS), Geriatric Depression Scale (GDS), State - Trait Anxiety Inventory (STAI), Montreal Cognitive Assessment (MoCA), Semantic Fluency Test (SFT), Hopkins Verbal Learning Test - Revised (HVLT - R), etc.
- **Biomarker assessment**: The levels of α - synuclein, total tau protein, phosphorylated tau protein, and β - amyloid 1 - 42 in cerebrospinal fluid (CSF) were assessed.

### Main findings

- **Relationship between skin conditions and PD risk**: The study found that any skin condition and basal cell carcinoma were related to an increased risk of PD (the adjusted ORs were 1.49 and 2.05 respectively), but these associations were no longer statistically significant after Bonferroni correction.
- **Impact of skin conditions in PD patients**: PD patients with skin conditions were older, had a higher education level, and performed better in the Semantic Fluency Test (SFT) and Hopkins Verbal Learning Test (HVLT) retention scores. However, these associations were also no longer significant after Bonferroni correction.
- **Biomarker analysis**: No significant association was found between the levels of α - synuclein, total tau protein, phosphorylated tau protein, and β - amyloid 1 - 42 in CSF and skin conditions.

### Conclusion

Although a certain association between skin conditions and PD was observed, especially in basal cell carcinoma, these associations were no longer significant after multiple comparison corrections. Therefore, the researchers suggest conducting larger - scale longitudinal studies in the future to further verify these findings. In addition, skin health may be a potential marker for distinguishing PD subtypes in the future, and further research is needed to confirm this.